Arman Oruc

Partner, Goodwin Procter

Arman Oruc is co-chair of the firm’s antitrust and competition practice. He specialises in antitrust-related issues, including regulatory clearance and approval of mergers and acquisitions, government investigations, antitrust litigation and antitrust risks associated with strategic business practices. Mr Oruc’s experience in both merger clearance and antitrust litigation, combined with his in-house experience, gives him a unique perspective in his practice. Mr Oruc has advised on antitrust issues associated with countless consummated and proposed transactions for private equity and public company clients. He has shepherded transactions through the Federal Trade Commission, the US Department of Justice and competition authorities outside of the United States. His litigation experience includes single company monopolisation cases, allegations of abuse of intellectual property, standard-setting activities, foreclosure allegations and successful amnesty applications in cartel investigations. Mr Oruc serves on Law360’s editorial advisory board for life sciences. Among other things, Mr Oruc was recognised in 2022 by LMG Life Sciences as a ‘Life Sciences Star’. Prior to joining Goodwin, Mr Oruc was part of the founding team of Biosplice Therapeutics, where he served as the chief legal officer and a member of the board. Prior to Biosplice, Mr Oruc was a partner in the antitrust practice of a leading international law firm.